Work

Mammalian Target of Rapamycin (mTOR) Inhibitors

Year: 2011

Type: article

Source: Drug Safety

DOI: 10.2165/11585040-000000000-00000

Authors: Sofia Sofroniadou, David Goldsmith

Institutions: Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, Kings Health Partners

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novartis Pharma

OpenAlex ID: W107867238

FWCI: 2.829

Cites: 136

Cited by: 60

Related to: 10